The largest investor initiative tackling climate change says after two years of talking to the most polluting companies, data show most haven’t aligned their businesses with the Paris accord and that its members need to ramp up pressure.
A California congresswoman plans to hold a hearing in about a month to explore the national-security risks posed by China’s dominance of the U.S. pharmaceutical supply chain, escalating concerns raised by the Pentagon.
Global health regulators sounded a coordinated alarm about the possibility that a stomach drug taken by millions of people could be tainted with the same cancer-causing agent that has sparked a worldwide recall of blood-pressure pills.
Suppliers existing on already thin margins are fearful of being beaten down on price by powerful buyers. So why would they embrace reserve auctions, which end up awarding contracts to the cheapest bidder?